Smith Nicholas Conrad's Form 4 filing
Alto Neuroscience, Inc. (ANRO) · filed Apr 1, 2024
- Accession no.
- 0001415889-24-009533
- Filed
- Apr 1, 2024
- Trade date
- Mar 28, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $100.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Nicholas ConradCIK 0002009130 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 28, 2024 | Common Stock | PPurchaseAcquired | +1,600 | $15.80 | +$25,280 | 22,316 | Direct | |
| Mar 28, 2024 | Common Stock | PPurchaseAcquired | +4,550 | $16.56 | +$75,348 | 26,866 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.